Artificial intelligence model comparison for risk factor analysis of patent ductus arteriosus in nationwide very low

Jae Yoon Na1, Dongkyun Kim2, Amy M Kwon3

  • 1Department of Pediatrics, Hanyang University College of Medicine, 222 Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea.

Scientific Reports
|November 17, 2021
PubMed

Insights

Artificial intelligence (AI) analysis accurately identified risk factors for symptomatic patent ductus arteriosus (sPDA) in very low birth weight infants. AI, particularly ensemble methods, outperformed traditional analysis in predicting sPDA.

Area of Science:

  • Neonatology
  • Medical Informatics
  • Pediatric Cardiology

Background:

  • Patent ductus arteriosus (PDA) is common in preterm infants, associated with high mortality and comorbidities.
  • Current risk factor studies for PDA often use small sample sizes, limiting generalizability.
  • Therapeutic strategies for PDA vary, highlighting the need for better risk identification.

Purpose of the Study:

  • To compare artificial intelligence (AI) analysis with conventional methods for identifying symptomatic PDA (sPDA) risk factors.
  • To evaluate the performance of AI algorithms in predicting sPDA in very low birth weight (VLBW) infants.
  • To leverage a large nationwide dataset for robust risk factor analysis.

Main Methods:

  • Nationwide cohort study of 8369 very low birth weight (VLBW) infants.
  • Categorization into symptomatic PDA (sPDA) and non-symptomatic PDA (nPDA) groups.
  • Analysis of 47 perinatal risk factors using multiple logistic regression and five AI algorithms (including ensemble methods).

Main Results:

  • AI analysis demonstrated higher accuracy and better performance in identifying sPDA risk factors compared to conventional methods.
  • Ensemble AI methods exhibited the best performance in predicting sPDA.
  • The study successfully combined a large registry database with AI for improved prediction.

Conclusions:

  • AI techniques, especially ensemble methods, offer superior performance in identifying risk factors for sPDA in VLBW infants.
  • Combining large-scale data with AI enhances the accuracy of PDA prediction.
  • This approach can inform clinical decision-making and improve outcomes for VLBW infants with PDA.